Clinical trials
Graves Ophthalmopathy trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Viridian Therapeutics, Inc. | 5 |
| Amgen | 3 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| Hoffmann-La Roche | 1 |
| Tourmaline Bio, Inc., a Novartis Company | 1 |
| University Hospital, Montpellier | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Ophthalmopathy | 13 |
| Graves Disease | 5 |
| Exophthalmos | 1 |
| Eye Diseases | 1 |
| Hyperthyroidism | 1 |
| Thyroid Diseases | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.